Meeting | Mixed
Event Title
Public Meeting on the Reauthorization of the Biosimilar User Fee Act (BsUFA)
October 26, 2026
Event Title
Public Meeting on the Reauthorization of the Biosimilar User Fee Act (BsUFA)
- Date:
- October 26, 2026
- Time:
- 9:00 a.m. - 12:00 p.m. ET
Attend
The Food and Drug Administration (FDA or Agency) is announcing a public meeting to discuss proposed recommendations for the reauthorization of the Biosimilar User Fee Act (BsUFA) for fiscal years (FYs) 2028 through 2032. The hybrid public meeting will be held on October 26, 2026, from 9 a.m. to 12 p.m. ET. The meeting agenda and additional materials will be posted to this page as they become available. For more background information on the meeting or to submit comments, please see the Federal Register notice with assigned docket FDA-2015-N-3326 issued on Friday, September 25th.
Public Docket
In addition to providing input at the public meeting, stakeholders are invited to provide their perspectives through the public docket.
- The docket closes on November 25, 2026
- Regulations.gov